COMPARATIVE STUDY
JOURNAL ARTICLE
MULTICENTER STUDY

Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry

Daniel Sürder, Giovanni Pedrazzini, Oliver Gaemperli, Patric Biaggi, Christian Felix, Kaspar Rufibach, Christof Auf der Maur, Raban Jeger, Peter Buser, Beat A Kaufmann, Marco Moccetti, David Hürlimann, Ines Bühler, Dominique Bettex, Jacques Scherman, Elena Pasotti, Francesco F Faletra, Michel Zuber, Tiziano Moccetti, Thomas F Lüscher, Paul Erne, Jürg Grünenfelder, Roberto Corti
Heart 2013, 99 (14): 1034-40
23343688

BACKGROUND: Percutaneous mitral valve repair (MVR) using the MitraClip system has become a valid alternative for patients with severe mitral regurgitation (MR) and high operative risk.

OBJECTIVE: To identify clinical and periprocedural factors that may have an impact on clinical outcome.

DESIGN: Multi-centre longitudinal cohort study.

SETTING: Tertiary referral centres.

PATIENTS: Here we report on the first 100 consecutive patients treated with percutaneous MVR in Switzerland between March 2009 and April 2011. All of them had moderate-severe (3+) or severe (4+) MR, and 62% had functional MR. 82% of the patients were in New York Heart Association (NYHA) class III/IV, mean left ventricular ejection fraction was 48% and the median European System for Cardiac Operative Risk Evaluation was 16.9%.

INTERVENTIONS: MitraClip implantation performed under echocardiographic and fluoroscopic guidance in general anaesthesia.

MAIN OUTCOME MEASURES: Clinical, echocardiographic and procedural data were prospectively collected.

RESULTS: Acute procedural success (APS, defined as successful clip implantation with residual MR grade ≤2+) was achieved in 85% of patients. Overall survival at 6 and 12 months was 89.9% (95% CI 81.8 to 94.6) and 84.6% (95% CI 74.7 to 91.0), respectively. Univariate Cox regression analysis identified APS (p=0.0069) and discharge MR grade (p=0.03) as significant predictors of survival.

CONCLUSIONS: In our consecutive cohort of patients, APS was achieved in 85%. APS and residual discharge MR grade are important predictors of mid-term survival after percutaneous MVR.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
23343688
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"